APYX — APYX MEDICAL CORPORATION
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About APYX MEDICAL CORPORATION (APYX)
APYX MEDICAL CORPORATION (APYX) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $966,994. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in APYX
How many top investors track APYX
A small number of top investors own this.
APYX Ownership Composition
How APYX MEDICAL CORPORATION is held across tracked investor types, based on reported 13F positions.
- Other91.4%
- Hedge Funds8.6%
Tracked investors reporting APYX
- Izzy EnglanderMar 31, 2026Millennium ManagementShares262.1KValue$967K% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares107.8KValue$397.8K% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares34.8KValue$128.3K% Portfolio0.00%
Recent activity
- $324.4KFeb 17, 2026
- $967KMay 15, 2026
- New$77.7KFeb 17, 2026
- New$397.8KMay 15, 2026
- New$128.3KMay 15, 2026
- New$28.4KNov 14, 2025
Frequently asked questions
- How many institutional investors hold APYX?
- 3 tracked institutional investors disclosed a position in APYX (APYX MEDICAL CORPORATION) in their most recent 13F filing.
- Who is the largest institutional holder of APYX?
- Izzy Englander, Millennium Management, holds the largest disclosed position in APYX, valued at $966,994.
- Did institutional ownership of APYX increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 fully exited APYX.
- Where does this APYX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.